NewAmsterdam Pharma N.V. (NAMS)
NASDAQ: NAMS
· Real-Time Price · USD
19.75
-0.46 (-2.28%)
At close: Jun 16, 2025, 3:59 PM
19.32
-2.18%
Pre-market: Jun 17, 2025, 04:18 AM EDT
NewAmsterdam Pharma Revenue
NewAmsterdam Pharma reported an annual revenue of $45.56M, reflecting a 257% growth. For the quarter ending March 31, 2025, NewAmsterdam Pharma generated $2.98M in revenue.
Revenue (ttm)
$45.56M
Revenue Growth
257%
Price / Sales Ratio
53.22
Revenue / Employee
$670.04K
Employees
68
Market Cap
2.22B
Revenue Chart
Revenue History
Fiscal Year End | Revenue | % Change |
---|